A comparative study of resveratrol and resveratrol‐functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties

Abstract

Deposition of amyloid‐β (Aβ) aggregates and formation of neurotoxic reactive oxygen species (ROS) are significant pathological signatures of Alzheimer's disease (AD). Resveratrol (Res) is an antioxidant with the potential to treat AD. However, the bioavailability and solubility of Res is very low and it cannot entirely inhibit Cu2+‐induced Aβ42 aggregation at low concentration. Herein, we combine the unique Aβ absorption property of selenium nanoparticles with the natural antioxidant agent Res to form Res@SeNPs. Our in vitro biological evaluation revealed that modification of Res with SeNPs provides a synergistic effect on Cu2+‐induced Aβ42 aggregation, ROS generation and, more importantly, protects PC12 cells from Aβ42–Cu2+ complexes‐induced cell death. It is believed that SeNPs can improve the application of Res in AD treatment as Res@SeNPs is more efficient than Res in reducing Aβ42 toxicity in long‐term use. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 3034–3041, 2018.

Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases

“…Several authors have reported interesting results concerning the use of SeNPs as a therapeutic agent for neurodegenerative diseases . Several works demonstrated that SeNPs are able to reduce Aβ aggregation and prevent Aβ‐induced toxicity in PC12 cells . In another work, SeNPs were able to reduce neuronal death, ROS levels, and behavioral disorders in a C. Elegans in vivo model of HD, by reducing also the aggregation of huntingtin protein .…”

The role of resveratrol in bone marrow‐derived mesenchymal stem cells from patients with osteoporosis

“…[13][14][15] Besides, resveratrol has multiple bioactivities of antioxidants, antiaging, insulin sensitization and plays a critical role in many diseases. [16][17][18] Several reports have showed that resveratrol was capable of decreasing the levels of blood glucose in diabetic rats, normal rats and mice and humans. 19,20 Resveratrol can interact with multiple molecular targets which are related to inflammation and immunity.…”

The Antiaggregative and Antiamyloidogenic Properties of Nanoparticles: A Promising Tool for the Treatment and Diagnostics of Neurodegenerative Diseases

“…Likewise, the same group designed SeNPs modified with resveratrol and tested their properties against ion metal-induced A β 42 aggregation. They obtained similar effects as described above, i.e., that resveratrol and SeNPs exhibit synergistic effect regarding the inhibition of pathological protein aggregation [ 54 ]. A nanocomposite engineered from quercetin, SeNPs, and polysorbate 80 can serve as another example of SeNPs combined with antioxidants.…”